secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quanterix Corp (QTRX)
CIK:        0001503274
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001503274-24-000006
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quanterix Q2 revenue up 11% to $34.4M; net loss widens to $9.5M; cuts FY2024 revenue guidance
--------------------------------------------------------------------------------

- Revenue $34.4M (+10.8% YoY); GAAP gross margin 58.3% vs 61.7% prior year.
- Net loss $9.5M, up $3.4M from prior year; cash usage $5.1M in quarter.
- Revised FY2024 revenue guidance to $134M-$138M from $139M-$144M due to constrained capital environment.
- Cash usage for 2024 now expected at higher end of $25M-$30M range.
- New Alzheimer's diagnostic partnerships with Mt. Sinai, Banner Health, UCSF, and KingMed Diagnostics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503274/000150327424000006/0001503274-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503274/000150327424000006/qtrx-20240808.htm
  HTML page:      https://secwatch.observer/filing/0001503274-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer